A Phase I Study to Assess the Safety and Immunogenicity of DNK-651 in Japanese Healthy Young Adults and Elderly Adults
Phase of Trial: Phase I
Latest Information Update: 04 Oct 2017
At a glance
- Drugs Influenza virus vaccine (Primary) ; Influenza virus vaccine
- Indications Influenza virus infections
- Focus Pharmacodynamics
- Acronyms DNK-651-1
- Sponsors Denka Seiken
- 29 Sep 2017 Status changed from active, no longer recruiting to completed.
- 09 Dec 2016 Status changed from recruiting to active, no longer recruiting.
- 18 Jun 2016 New trial record